News

> Vaiomer will be taking part in the 4th edition of the « Journées Polepharma De Microbiomique » on November 22 & 23 in Rouen, FRANCE.
> Do not miss the amazing “Microbiota and Cancer” session introduced by our CSO, Benjamin LELOUVIER, on Thursday 23 at 14:00.

>We are excited to exchange and share new ideas with scientists and academics in the field of microbiota and Alzheimer’s research.
>Do not miss our talk presented by Benjamin LELOUVIER in the Microbiota session, on Wednesday, November 15.

> Vaiomer will be attending “Genotoul Scientific Day-HOLOBIONTES: Understanding host microbiota interactions” Thursday, November 9, 2023 in Toulouse, France.

> Looking forward to fruitful discussions with the participants, at «la 10e édition des AFSSI Connexions» on July 04 and 05.

> Vaiomer will be participating to « la deuxième édition de LA JOURNÉE DU MICROBIOTE», on June 27 in Paris, FRANCE.
> Do not miss our talk on Exploring the microbiome beyond the gut: Example of skin microbiota alteration by tick bites. More

Physiogenex, a leading preclinical contract research organization specialized in metabolic diseases and complications, and Vaiomer, a pioneer company in the field of microbiota, launch the TRANSBIOTIC project: a new research project to transplant mice with human fecal microbiome isolated from patients suffering various metabolic and inflammatory diseases.

> Vaiomer will be taking part in the 3rd edition of the « Journées Polepharma De Microbiomique » on December 14th & 15th in Rouen, FRANCE.
> Join us on our booth #11 to learn more about microbiomes beyond the gut.
> Do not miss our talk on exploring the microbiomes from gut and beyond, Thursday 15th at 14:35.

> Vaiomer is taking part in the meeting “Advanced Concepts In Neuroimmunology: From Environmental Stressors To Neurological Disorders” on November 24 in Strasbourg, FRANCE.
> Do not miss our talk on “Tissue microbiota analysis for pathogen identification and skin microbiome alteration assessment after tick bite” at 14:45.

> Meet Vaiomer at the Microbiome R&D and Business Collaboration Forum on May 24 & 25, in The Hague, THE NETHERLANDS
> Come visit our booth and do not miss our talk “Bacterial translocation: a new perspective on the microbiota-gut-brain axis?”
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.

> Vaiomer will be participating to Oncology: Horizon 2030 Technologies and models to address tumor heterogeneity for better personalized medicine, on May 12 in Toulouse, FRANCE.
> Do not miss our talk on how microbiomes contribute to tumor microenvironment, progression and treatment responsiveness.